| Document |
Document Title |
|
WO/2009/121486A1 |
The invention relates to a continuous method for producing amides, according to which at least one carboxylic acid of formula (I) R3-COOH (I), wherein R3 is an optionally substituted alkenyl group comprising between 2 and 4 carbon atoms,...
|
|
WO/2009/121940A1 |
The present invention is directed to a novel process for the preparation of (4-chloro-phenyl)-(3-thfluoromethyl-phenoxy)-acetic acid 2-acetylamino-ethyl ester, useful in the treatment of metabolic disorders and further to a process for t...
|
|
WO/2009/121487A1 |
The invention relates to a continuous method for producing fatty acid amides, according to which at least one fatty acid of formula R3-COOH (I), wherein R3 is an optionally substituted aliphatic hydrocarbon radical, is reacted with at le...
|
|
WO/2009/124022A1 |
The invention provides amino- and amido-aminotetralin compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, R7, and n are defined in the specification, or a pharmaceutically-acceptable salt thereof, that are antagonists at the mu opio...
|
|
WO/2009/123109A1 |
A photosensitive transparent resin composition which is reduced in the dependence on exposure illuminance and which can stably form patterns excellent in resolution with high retention of film thickness and nearly without scum; color fil...
|
|
WO/2009/121484A1 |
The invention relates to a continuous method for producing amides of aromatic carboxylic acids, according to which at least one aromatic carboxylic acid of formula (I) Ar-COOH, wherein Ar is an optionally substituted aryl radical compris...
|
|
WO/2009/121488A1 |
The invention relates to a method for producing carboxylic acid amides, according to which at least one carboxylic acid of formula (I) R3-COOH (I), wherein R3 is hydrogen or an optionally substituted hydrocarbon radical comprising betwee...
|
|
WO/2009/121490A1 |
The invention relates to a continuous method for producing amides, according to which at least one carboxylic acid of formula (I) R3-COOH (I), wherein R3 is hydrogen or an optionally substituted alkyl group comprising between 1 and 4 car...
|
|
WO/2009/121485A1 |
The invention relates to a continuous method for producing fatty acid alkanol amides, wherein at least one fatty acid of the formula (I) R3-COOH, where R3 is an optionally substituted aliphatic hydrocarbon radical with 5 to 50 carbon ato...
|
|
WO/2009/121788A1 |
A process for the preparation of a compound of formula (Ia): which are useful as intermediates in the preparation of i.a. pharmaceutically active compounds.
|
|
WO/2009/119858A1 |
Disclosed is a novel benzene compound which has an excellent immunosuppressing activity, an excellent rejection-inhibiting effect and others, and is reduced in adverse side effects including bradycardia. Specifically disclosed is a compo...
|
|
WO/2009/118168A1 |
The invention relates to compounds which have an affinity to the µ-opioid receptor and ORL1 receptor, to processes for preparation thereof, to medicaments comprising these compounds and to the use of these compounds for producing medica...
|
|
WO/2009/118493A2 |
The invention relates to the continuous aqueous-phase synthesis of an N-acylated compound including a unit (M1) of the formula (I) in which n is 0, 1 or 2 and R1 is an aliphatic radical, wherein said synthesis comprises: the step A of re...
|
|
WO/2009/117317A1 |
A method of removing a carboxylic acid from a liquid that contains a tertiary amide solvent includes a step of contacting the liquid with an extraction medium comprising an amine. The amine is immiscible with both water and the tertiary ...
|
|
WO/2009/114950A1 |
The present application relates to pyrrolidine, piperidine, and other nitrogen-containing heterocyclic derivatives and the use of these compounds for treating and preventing pam or inflammation. The analgesic compounds demonstrate effica...
|
|
WO/2009/115334A2 |
The present invention relates to a process for manufacturing N-Formyl-1-amino-3,5-dimethyladamantane, an intermediate product in the overall process of producing 1-Amino-3,5-dimethyladamantane hydrochloride (Memantine). Therein, the proc...
|
|
WO/2009/115534A1 |
The present invention relates to improved processes for the production of 2-amino-2-[2-(4- C2-20-alkyl-phenyl)ethyl]propane-1,3-diols, and to compounds for use therein.
|
|
WO/2009/114966A1 |
The process for preparing tamibarotene II type crystal of a single heat-absorptive peak near 233 oC in differential scanning thermal analysis. The process comprises the following steps: using low carbon organic acids (preferred acetic ac...
|
|
WO/2009/115707A2 |
The present invention relates to the preparation of compounds of formula (I) derived from arylacetic acid comprising two phenol functions and an amide function, which have free-radical scavenging and antioxidant properties and which are ...
|
|
WO/2009/112615A1 |
The invention applies to the field of pharmacology and medical chemistry and relates to novel molecules represented by general formula (I), especially referred to as FM19G11, and to pharmaceutical compositions containing same. Said pharm...
|
|
WO/2009/113617A1 |
Disclosed is a method which can stabilize an aqueous acrylamide solution conveniently by using a stabilizer that can be separated and removed readily. Specifically disclosed is a method for stabilizing an aqueous acrylamide solution, whi...
|
|
WO/2009/109792A1 |
New chiral stationary phases (CSPs) based on chiral selectors covalently bound on a solid support were prepared. Chiral selectors were obtained from enantiomerically pure aromatic amines and 3,5-dinitrobenzoic acid and then linked to the...
|
|
WO/2009/110002A1 |
This invention relates to compounds, which are in general potentiators of antiinfeective agents and inhibitors of bacterial efflux pumps in particular. These novel compounds i.e. substituted dihydronaphtalene derivatives and tetralin der...
|
|
WO/2009/110217A1 |
Provided is a hydroxyapatite with silver supported on the surface thereof, which is a novel compound useful as a catalyst in a reaction where a nitrile compound is hydrated to obtain a corresponding amide compound. The hydroxyapatite wit...
|
|
WO/2009/107762A1 |
Disclosed is a compound represented by general formula (I), which affects the gene transcription process. (I) (In the formula, R1 and R2 each represents a hydrogen atom, an alkyl group, a halogen atom or the like; R3 and R4 each represen...
|
|
WO/2009/106552A2 |
The present invention relates to a class of compounds and to diagnostic compositions containing such compounds where the compounds are iodine containing compounds. More specifically the iodine containing compounds are chemical compounds ...
|
|
WO/2009/103666A2 |
The present invention relates to a process for the preparation of iodinatedphenols,- in particular, it relates to a process including the electrochemical iodination of 3,5- disubstituted phenols of formula (1) to the corresponding 3, 5-d...
|
|
WO/2009/103778A1 |
A compound of formula (1) as well as pharmaceutically acceptable salts thereof, and a pharmaceutical composition comprising the compound. The compound is useful for the treatment of disorder selected from pain, fever, inflammation and ca...
|
|
WO/2009/100095A1 |
Compounds according to the formula below are disclosed herein: Therapeutic methods for the treatment of pain, compositions, and medicaments related thereto are also disclosed.
|
|
WO/2009/098458A2 |
A compound of formula (1): or formula (2) for treating ocular hypertension.
|
|
WO/2009/099901A1 |
Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions that include the compounds described herein, and methods of using such antagonists of PGD2 receptors, alone or in combi...
|
|
WO/2009/098251A1 |
The present invention relates to cycloalkanone β-substituted alanine derivatives, a process for the preparation of cycloalkanone β-substituted alanine derivatives and the use of cycloalkanone β-substituted alanine derivatives in the p...
|
|
WO/2009/098287A1 |
The present invention is related to a family of phenyl-prenyl derivatives of formula (I), and to their use in the treatment of cognitive, neurodegenerative or neuronal diseases or disorders, such as Alzheimer's disease or Parkinson's Dis...
|
|
WO/2009/096526A1 |
Provided is a compound having a CRTH2 antagonism and being useful as a preventive and/or remedy for inflammatory diseases (for example, asthma, allergic rhinitis, allergic dermatitis, conjunctivitis, urticaria, eosinophilic bronchitis, f...
|
|
WO/2009/095555A1 |
The invention relates to the crystalline form VI of the compound of the formula (I) that is characterised by its powder X-diffraction diagram. The invention can be used in drugs.
|
|
WO/2009/094807A1 |
The present invention relates to compounds from mycelium of Antrodia cinnamomea. The present invention also relates to a composition and a method for treating or prophylaxis of hepatitis C virus (HCV) infection.
|
|
WO/2009/095522A1 |
The invention relates to the preparation of novel taxane analogues and intermediates prepared from cyclohexenones in which ring C is incorporated into the polycyclic system, as well as to a novel method for accessing these compounds. Sai...
|
|
WO/2009/093028A2 |
A compound which undergoes a colour change upon irradiation, and which has the general structure: X-C≡C-C≡C-Y-(CO)n-QZ wherein X is H, alkyl or -Y-(CO)n-QW; each Y is the same or a different divalent alkylene group; Q is O, S or NR; ...
|
|
WO/2009/092284A1 |
Benzocycloheptene derivatives, preparing processes and pharmaceutical uses thereof. More particularly, the compounds of formula I or their pharmaceutically acceptable salts or hydrates which have activity of anti-HIV, wherein the definit...
|
|
WO/2009/091774A1 |
The invention relates to a composition containing a particulate solid, a plastic material (such as a thermoplastic polymer) and a compound containing an amide group. The compound is capable of being a dispersant. The invention further re...
|
|
WO/2009/091040A1 |
Disclosed is a method for producing a spilanthol on a large scale without using any expensive reagent. Specifically disclosed is a method for producing N-isobutyl-2,6,8-decatrienamide, which is characterized in that no purification proce...
|
|
WO/2009/087994A1 |
Disclosed is a method for dehalogenating an aromatic halide, wherein a hydrogen gas is brought into contact with a liquid mixture which is obtained by adding an object aromatic halide into water serving as a solvent or an organic solvent...
|
|
WO/2009/087062A2 |
The present invention relates to polymorphic forms of Oseltamivir phosphate, especially the (3R,4R,5S)-5-amino-4-acetylamino-3-(1-ethyl-propoxy)-cyclohe
x-1-ene-carboxylic acid ethyl ester phosphate, which is a potent inhibitor of viral ...
|
|
WO/2009/089192A1 |
The present invention provides novel phenoxyacetic acids useful for the prevention and treatment of inflammatory disorders, including those affecting the respiratory system and skin. The compounds are of the general formula (I):
|
|
WO/2009/088831A2 |
Disclosed are methods of enhancing the chemotherapeutic treatment of tumor cells, reducing resistance of a cancer cell to a chemotherapeutic agent, a method of inhibiting ABCG2, Pgp, or MRP1 in a mammal afflicted with cancer, and a metho...
|
|
WO/2009/084520A1 |
Disclosed is a method for producing N-methyl-N-vinylacetamide, which comprises a step for controlling the N-1,3-butadienyl-N-methylacetamide content in N-methyl-N-vinylacetamide to 0.01-150 ppm. This method enables production of N-methyl...
|
|
WO/2009/080769A1 |
A compound of general formula (I), wherein, R11, R12, R13, R14, R15, W, Y, R1, R2, R3, R4, R5, and R6 take various meanings for use in the treatment of cancer.
|
|
WO/2009/079763A1 |
A compound of Formula I : The compound can be used in the treatment of epilepsy, neuropathic pain, acute and chronic inflammatory pain, migraine, tardive dyskinesia and other related CNS disorders.
|
|
WO/2009/077385A1 |
Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing...
|
|
WO/2009/078813A1 |
A process is provided for the synthesis of 4,5-diamino cyclohexene carboxylate ester (1): or a pharmaceutically acceptable salt thereof. R1 - R3 are a silyl-, an aliphatic, alicyclic, aromatic, arylaliphatic, or an arylalicyclic group. R...
|
